Maximum quantity allowed is 999
Please select the quantity
CAS RN: 52-86-8 | Product Number: H0912
Haloperidol
×
![]()
×
Purity: >98.0%(T)(HPLC)
Chemical Substance Law (ENCS):
9-1138
Synonyms:
- 4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone
Documents:
| Size | Unit Price | Saitama (Kawaguchi) | Hyogo (Amagasaki) | Stock in other WH |
|---|---|---|---|---|
| 5G |
¥4,500
|
≥20 | 18 | ≥20 |
| 25G |
¥13,500
|
≥20 | Contact Us | ≥20 |
Available Stock: Prompt shipment (for products) in Saitama/Hyogo warehouse. Stock in other WH: 2-3 Business Days
* Please contact us if you need further information.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* Please contact us if you need further information.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | H0912 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__1H__2__3ClFNO__2 = 375.87 |
| Physical State (20 deg.C) | Solid |
| CAS RN | 52-86-8 |
| Reaxys Registry Number | 331267 |
| PubChem Substance ID | 87571270 |
| SDBS (AIST Spectral DB) | 14024 |
| Merck Index (14) | 4598 |
| MDL Number | MFCD00051423 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Solubility in Acetic acid | almost transparency |
| Melting point | 150.0 to 153.0 °C |
Properties (reference)
| Melting Point | 152 °C |
| Solubility in water | Insoluble |
| Solubility (soluble in) | Benzene,Acetone,Chloroform |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H301 : Toxic if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. H360 : May damage fertility or the unborn child. H362 : May cause harm to breast-fed children. H370 : Causes damage to organs. H372 : Causes damage to organs through prolonged or repeated exposure. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P263 : Avoid contact during pregnancy/ while nursing. P260 : Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P311 : IF exposed or concerned: Call a POISON CENTER/doctor. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
Related Laws:
| Chemical Substance Law (ENCS) |
9-1138 |
| RTECS# | EU1575000 |
Transport Information:
| UN Number | UN2811 |
| Class | 6.1 |
| Packing Group | III |
Application
Haloperidol: A Dopamine Receptor (D2) and a Serotonin Receptor (5-HT2) Antagonist
Haloperidol is a butyrophenone series of neurotransmitter agent. The precise mechanism of action has not been clearly established, but it has been shown to be a dopamine receptor (D2) and a serotonin receptor (5-HT2) antagonist. Therefore, haloperidol is classified as a neuroleptic. Haloperidol is metabolized by several routes including the cytochrome P450 enzyme system (particularly CYP3A4 or CYP2D6). Hence, haloperidol inhibits the metabolism of tricyclic antidepressants such as doxepin hydrochloride [D4626] and imipramine hydrochloride [I0971] , increasing the blood levels of these agents. Haloperidol has no anti-histaminergic or anticholinergic activity. Haloperidol is almost insoluble in water, but is soluble in most organic solvents. (The product is for research purpose only.)
References
- Serotonergic involvement in haloperidol-induced catalepsy
- A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex
- Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist
- Pharmacokinetics of haloperidol: an update (a review)
- Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number
Incorrect Lot Number is entered
The requested analytical chart is not available. Sorry for the inconvenience.